Now Reading: Andhra Pradesh, AstraZeneca sign deal for genomic cancer centre
-
01
Andhra Pradesh, AstraZeneca sign deal for genomic cancer centre
On Tuesday, the Andhra Pradesh government signed an MoU with AstraZeneca India to establish an Integrated Genomic Solutions Centre in Amaravati, focusing on precision oncology. The centre will offer genomic testing and…
The Story in Brief
On Tuesday, the Andhra Pradesh government signed an MoU with AstraZeneca India to establish an Integrated Genomic Solutions Centre in Amaravati, focusing on precision oncology. The centre will offer genomic testing and biomarker analysis for lung and breast cancers, using next-generation sequencing, AI, and genomic technologies for early detection and personalised treatment.
As part of the pact, AI-enabled X-ray systems will be installed in government hospitals to boost lung cancer screening. Chief Minister N. Chandrababu Naidu said the initiative, under the Amaravati Quantum Valley programme, would make advanced healthcare accessible and turn the city into a research hub. Reliance-backed Strand Life Sciences and Qure.ai are also partners.
The Indian Opinion
Such well-publicised MoUs often raise hopes but fade when it comes to ground-level delivery. The real test will be whether the genomic centre begins operations within a year and whether the AI X-ray systems actually reach district hospitals. Also, without a clear subsidised pricing model, precision medicine could remain a luxury for the rich. Will the government ensure affordable access for all?
Source: thehindu.com
This story was synthesised by AI from the source linked above.
